论文部分内容阅读
Objective:To investigate inflammatory factor change in serious heart valve replacement and the influence of the organ function.Methods:60 cases of heart valve replacement of the first time is randomly divided into Ulinastatin group (A group),Ulinastatin and Aprotinin group (B group) and matched control (C group),20 respectively.